Kaberi Das
10PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.Christine E Birdwell, Warren Fiskus, Christopher P Mill
|Aug 19, 2025
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase.Warren Fiskus, Lucia Masarova, Christopher P Mill
|Nov 19, 2024
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.Warren Fiskus, Christopher P Mill, Prithviraj Bose
|Mar 04, 2024
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor.Warren Fiskus, Jessica Piel, Mike Collins
|Dec 12, 2023
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.Christine E Birdwell, Warren Fiskus, Tapan M Kadia
|Mar 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1.Christopher P Mill, Warren Fiskus, Kaberi Das
Pageof 2
Frequent Collaborators
8 joint publications
Warren Fiskus
8 joint publications
Courtney DiNardo
7 joint publications
Christopher P Mill
6 joint publications
Naval Daver
6 joint publications
Sanam Loghavi
5 joint publications
Hanxi Hou
5 joint publications
Kapil N Bhalla
5 joint publications
Tapan M Kadia
5 joint publications
Anna Malovannaya
4 joint publications
Koji Sasaki
